Loading...

Jan Nolta

TitleProf
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pham MT, Pollock KM, Rose MD, Cary WA, Stewart HR, Zhou P, Nolta J, Waldau B. Generation of human vascularized brain organoids. Neuroreport. 2018 May 02; 29(7):588-593. PMID: 29570159.
      View in: PubMed
    2. Nolta J. Research Leads to Approved Therapies in the New Era of Living Medicine. Stem Cells. 2018 Jan; 36(1):1-3. PMID: 29210150.
      View in: PubMed
    3. Feng JF, Liu J, Zhang L, Jiang JY, Russell M, Lyeth BG, Nolta J, Zhao M. Electrical Guidance of Human Stem Cells in the Rat Brain. Stem Cell Reports. 2017 Jul 11; 9(1):177-189. PMID: 28669601.
      View in: PubMed
    4. Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta J, Park SS. Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia. Curr Eye Res. 2017 10; 42(10):1358-1367. PMID: 28636406.
      View in: PubMed
    5. Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA. Pediatr Res. 2017 Sep; 82(3):527-535. PMID: 28419087.
      View in: PubMed
    6. Kuhn MA, Black AB, Siddiqui MT, Nolta J, Belafsky PC. Novel murine xenograft model for the evaluation of stem cell therapy for profound dysphagia. Laryngoscope. 2017 Oct; 127(10):E359-E363. PMID: 28543406.
      View in: PubMed
    7. Fierro FA, Nolta J, Adamopoulos IE. Concise Review: Stem Cells in Osteoimmunology. Stem Cells. 2017 06; 35(6):1461-1467. PMID: 28390147.
      View in: PubMed
    8. Harding A, Cortez-Toledo E, Magner NL, Beegle JR, Coleal-Bergum DP, Hao D, Wang A, Nolta J, Zhou P. Highly Efficient Differentiation of Endothelial Cells from Pluripotent Stem Cells Requires the MAPK and the PI3K Pathways. Stem Cells. 2017 04; 35(4):909-919. PMID: 28248004.
      View in: PubMed
    9. Nolta J. Cutting Edge Advances in Stem Cell Biology and Therapy. Stem Cells. 2017 01; 35(1):1-2. PMID: 27873381.
      View in: PubMed
    10. Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A, Zawadzki RJ, Werner JS, Nolta J. Advances in bone marrow stem cell therapy for retinal dysfunction. Prog Retin Eye Res. 2017 Jan; 56:148-165. PMID: 27784628.
      View in: PubMed
    11. Beegle JR, Magner NL, Kalomoiris S, Harding A, Zhou P, Nacey C, White JL, Pepper K, Gruenloh W, Annett G, Nolta J, Fierro FA. Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia. Mol Ther Methods Clin Dev. 2016; 3:16053. PMID: 27610394; PMCID: PMC5003097.
    12. Moisseiev E, Smit-McBride Z, Oltjen S, Zhang P, Zawadzki RJ, Motta M, Murphy CJ, Cary W, Annett G, Nolta J, Park SS. Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration. Invest Ophthalmol Vis Sci. 2016 08 01; 57(10):4125-35. PMID: 27537262.
      View in: PubMed
    13. Satake N, Duong C, Yoshida S, Oestergaard M, Chen C, Peralta R, Guo S, Seth PP, Li Y, Beckett L, Chung J, Nolta J, Nitin N, Tuscano JM. Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate. Mol Med. 2016 Jul 22; 22. PMID: 27455414.
      View in: PubMed
    14. Deng P, Anderson JD, Yu AS, Annett G, Fink KD, Nolta J. Engineered BDNF producing cells as a potential treatment for neurologic disease. Expert Opin Biol Ther. 2016 08; 16(8):1025-33. PMID: 27159050.
      View in: PubMed
    15. Deng P, Torrest A, Pollock K, Dahlenburg H, Annett G, Nolta J, Fink KD. Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells. Neural Regen Res. 2016 May; 11(5):702-5. PMID: 27335539; PMCID: PMC4904446.
    16. Nolta J. "Next-generation" mesenchymal stem or stromal cells for the in vivo delivery of bioactive factors: progressing toward the clinic. Transfusion. 2016 Apr; 56(4):15S-7S. PMID: 27079315.
      View in: PubMed
    17. Kalomoiris S, Cicchetto AC, Lakatos K, Nolta J, Fierro FA. Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem Cells. J Cell Biochem. 2016 09; 117(9):2128-37. PMID: 26888666.
      View in: PubMed
    18. Anderson JD, Johansson HJ, Graham CS, Vesterlund M, Pham MT, Bramlett CS, Montgomery EN, Mellema MS, Bardini RL, Contreras Z, Hoon M, Bauer G, Fink KD, Fury B, Hendrix KJ, Chedin F, El-Andaloussi S, Hwang B, Mulligan MS, Lehtiö J, Nolta J. Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling. Stem Cells. 2016 Mar; 34(3):601-13. PMID: 26782178.
      View in: PubMed
    19. Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Annett G, Wheelock V, Segal DJ, Nolta J. Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts. Cell Transplant. 2016; 25(4):677-86. PMID: 26850319.
      View in: PubMed
    20. Lakatos K, Kalomoiris S, Merkely B, Nolta J, Fierro FA. Mesenchymal Stem Cells Respond to Hypoxia by Increasing Diacylglycerols. J Cell Biochem. 2016 Feb; 117(2):300-7. PMID: 26212931.
      View in: PubMed
    21. Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, D Anderson J, McGee J, Gruenloh W, Fury B, Bauer G, Duffy A, Tempkin T, Wheelock V, Nolta J. Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. Mol Ther. 2016 05; 24(5):965-77. PMID: 26765769; PMCID: PMC4881765.
    22. Jung Y, Nolta J. BMI1 Regulation of Self-Renewal and Multipotency in Human Mesenchymal Stem Cells. Curr Stem Cell Res Ther. 2016; 11(2):131-40. PMID: 26763885.
      View in: PubMed
    23. Black AB, Dahlenburg H, Pepper K, Nacey C, Pontow S, Kuhn MA, Belafsky PC, Nolta J. Human Myoblast and Mesenchymal Stem Cell Interactions Visualized by Videomicroscopy. Hum Gene Ther Methods. 2015 Dec; 26(6):193-6. PMID: 26544924.
      View in: PubMed
    24. Kol A, Arzi B, Athanasiou KA, Farmer DL, Nolta J, Rebhun RB, Chen X, Griffiths LG, Verstraete FJ, Murphy CJ, Borjesson DL. Companion animals: Translational scientist's new best friends. Sci Transl Med. 2015 Oct 07; 7(308):308ps21. PMID: 26446953; PMCID: PMC4806851 [Available on 10/07/16].
    25. McMahill BG, Spriet M, Sisó S, Manzer MD, Mitchell G, McGee J, Garcia TC, Borjesson DL, Sieber-Blum M, Nolta J, Sturges BK. Feasibility Study of Canine Epidermal Neural Crest Stem Cell Transplantation in the Spinal Cords of Dogs. Stem Cells Transl Med. 2015 Oct; 4(10):1173-86. PMID: 26273065; PMCID: PMC4572898 [Available on 10/01/16].
    26. Vapniarsky N, Arzi B, Hu JC, Nolta J, Athanasiou KA. Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine. Stem Cells Transl Med. 2015 Oct; 4(10):1187-98. PMID: 26253713; PMCID: PMC4572907 [Available on 10/01/16].
    27. Sheu J, Beltzer J, Fury B, Wilczek K, Tobin S, Falconer D, Nolta J, Bauer G. Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor. Mol Ther Methods Clin Dev. 2015; 2:15020. PMID: 26151065; PMCID: PMC4470365.
    28. Cary WA, Hori CN, Pham MT, Nacey CA, McGee JL, Hamou M, Berman RF, Bauer G, Nolta J, Waldau B. Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells From Acutely Harvested Dura Mater Obtained During Ventriculoperitoneal Shunt Surgery. World Neurosurg. 2015 Nov; 84(5):1256-66.e1. PMID: 26074438.
      View in: PubMed
    29. Beegle J, Lakatos K, Kalomoiris S, Stewart H, Isseroff RR, Nolta J, Fierro FA. Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo. Stem Cells. 2015 Jun; 33(6):1818-28. PMID: 25702874.
      View in: PubMed
    30. Osborn SL, So M, Hambro S, Nolta J, Kurzrock EA. Inosculation of blood vessels allows early perfusion and vitality of bladder grafts--implications for bioengineered bladder wall. Tissue Eng Part A. 2015 Jun; 21(11-12):1906-15. PMID: 25794892; PMCID: PMC4449700.
    31. Barclay SL, Yang Y, Zhang S, Fong R, Barraza A, Nolta J, Torbett BE, Abedi M, Bauer G, Anderson JS. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells. Stem Cells. 2015 Mar; 33(3):870-9. PMID: 25524029.
      View in: PubMed
    32. Nolta J. New advances in understanding stem cell fate and function. Stem Cells. 2015 Feb; 33(2):313-5. PMID: 25446041.
      View in: PubMed
    33. McMahill BG, Borjesson DL, Sieber-Blum M, Nolta J, Sturges BK. Stem cells in canine spinal cord injury--promise for regenerative therapy in a large animal model of human disease. Stem Cell Rev. 2015 Feb; 11(1):180-93. PMID: 25173879.
      View in: PubMed
    34. Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta J. Developing stem cell therapies for juvenile and adult-onset Huntington's disease. Regen Med. 2015; 10(5):623-46. PMID: 26237705.
      View in: PubMed
    35. Chang AI, Schwertschkow AH, Nolta J, Wu J. Involvement of mesenchymal stem cells in cancer progression and metastases. Curr Cancer Drug Targets. 2015; 15(2):88-98. PMID: 25619387.
      View in: PubMed
    36. Barisone GA, Satake N, Lewis C, Duong C, Chen C, Lam KS, Nolta J, D?az E. Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells. Blood Cells Mol Dis. 2015 Apr; 54(4):329-35. PMID: 25554682; PMCID: PMC4387021.
    37. Park SS, Bauer G, Abedi M, Pontow S, Panorgias A, Jonnal R, Zawadzki RJ, Werner JS, Nolta J. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci. 2014 Dec 09; 56(1):81-9. PMID: 25491299.
      View in: PubMed
    38. Gao W, Zhou P, Ma X, Tschudy-Seney B, Chen J, Magner NL, Revzin A, Nolta J, Zern MA, Duan Y. Ethanol negatively regulates hepatic differentiation of hESC by inhibition of the MAPK/ERK signaling pathway in vitro. PLoS One. 2014; 9(11):e112698. PMID: 25393427; PMCID: PMC4231066.
    39. Satake N, Duong C, Chen C, Barisone GA, Diaz E, Tuscano J, Rocke DM, Nolta J, Nitin N. Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia. Br J Haematol. 2014 Nov; 167(4):487-99. PMID: 25196579.
      View in: PubMed
    40. Perez-Cunningham J, Ames E, Smith RC, Peter AK, Naidu R, Nolta J, Murphy WJ. Natural killer cell subsets differentially reject embryonic stem cells based on licensing. Transplantation. 2014 May 27; 97(10):992-8. PMID: 24704665.
      View in: PubMed
    41. Clark EA, Kalomoiris S, Nolta J, Fierro FA. Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem Cells. 2014 May; 32(5):1074-82. PMID: 24860868.
      View in: PubMed
    42. Dasu MR, Ramirez SR, La TD, Gorouhi F, Nguyen C, Lin BR, Mashburn C, Stewart H, Peavy TR, Nolta J, Isseroff RR. Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healing. Stem Cells Transl Med. 2014 Jun; 3(6):745-59. PMID: 24760207; PMCID: PMC4039457.
    43. Osborn SL, Thangappan R, Luria A, Lee JH, Nolta J, Kurzrock EA. Induction of human embryonic and induced pluripotent stem cells into urothelium. Stem Cells Transl Med. 2014 May; 3(5):610-9. PMID: 24657961; PMCID: PMC4006482.
    44. Gericota B, Anderson JS, Mitchell G, Borjesson DL, Sturges BK, Nolta J, Sieber-Blum M. Canine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury. Stem Cells Transl Med. 2014 Mar; 3(3):334-45. PMID: 24443004; PMCID: PMC3952930.
    45. Nolta J. Editorial: 2013 - a year of clinical success and great scientific innovation in the stem cell field. Stem Cells. 2014 Jan; 32(1):1-2. PMID: 24375745.
      View in: PubMed
    46. Binder BY, Sondergaard CS, Nolta J, Leach JK. Lysophosphatidic acid enhances stromal cell-directed angiogenesis. PLoS One. 2013; 8(12):e82134. PMID: 24312635; PMCID: PMC3846884.
    47. Lee JK, Responte DJ, Cissell DD, Hu JC, Nolta J, Athanasiou KA. Clinical translation of stem cells: insight for cartilage therapies. Crit Rev Biotechnol. 2014 Mar; 34(1):89-100. PMID: 24083452; PMCID: PMC4314285.
    48. Plowman EK, Bijangi-Vishehsaraei K, Halum S, Cates D, Hanenberg H, Domer AS, Nolta J, Belafsky PC. Autologous myoblasts attenuate atrophy and improve tongue force in a denervated tongue model: a pilot study. Laryngoscope. 2014 Feb; 124(2):E20-6. PMID: 23929623.
      View in: PubMed
    49. Yik JH, Li H, Acharya C, Kumari R, Fierro F, Haudenschild DR, Nolta J, Di Cesare PE. The Oncogene LRF Stimulates Proliferation of Mesenchymal Stem Cells and Inhibits Their Chondrogenic Differentiation. Cartilage. 2013 Oct; 4(4):329-38. PMID: 26069677; PMCID: PMC4297155.
    50. Magner NL, Jung Y, Wu J, Nolta J, Zern MA, Zhou P. Insulin and IGFs enhance hepatocyte differentiation from human embryonic stem cells via the PI3K/AKT pathway. Stem Cells. 2013 Oct; 31(10):2095-103. PMID: 23836547.
      View in: PubMed
    51. Yao W, Guan M, Jia J, Dai W, Lay YA, Amugongo S, Liu R, Olivos D, Saunders M, Lam KS, Nolta J, Olvera D, Ritchie RO, Lane NE. Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells. 2013 Sep; 31(9):2003-14. PMID: 23818248; PMCID: PMC3795809.
    52. Ma X, Duan Y, Tschudy-Seney B, Roll G, Behbahan IS, Ahuja TP, Tolstikov V, Wang C, McGee J, Khoobyari S, Nolta J, Willenbring H, Zern MA. Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells. Stem Cells Transl Med. 2013 Jun; 2(6):409-19. PMID: 23681950; PMCID: PMC3673753.
    53. Kalomoiris S, Lawson J, Chen RX, Bauer G, Nolta J, Anderson JS. CD25 preselective anti-HIV vectors for improved HIV gene therapy. Hum Gene Ther Methods. 2012 Dec; 23(6):366-75. PMID: 23216020; PMCID: PMC4015076.
    54. Annett G, Bauer G, Nolta J. Mesenchymal stem cells for trinucleotide repeat disorders. Methods Mol Biol. 2013; 1010:79-91. PMID: 23754220; PMCID: PMC3815662.
    55. Liu J, Githinji J, Mclaughlin B, Wilczek K, Nolta J. Role of miRNAs in neuronal differentiation from human embryonic stem cell-derived neural stem cells. Stem Cell Rev. 2012 Dec; 8(4):1129-37. PMID: 23054963; PMCID: PMC4559349.
    56. Kumari R, Li H, Haudenschild DR, Fierro F, Carlson CS, Overn P, Gupta L, Gupta K, Nolta J, Yik JH, Di Cesare PE. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance. Carcinogenesis. 2012 Nov; 33(11):2076-83. PMID: 22847180.
      View in: PubMed
    57. Liu J, Koscielska KA, Cao Z, Hulsizer S, Grace N, Mitchell G, Nacey C, Githinji J, McGee J, Garcia-Arocena D, Hagerman RJ, Nolta J, Pessah IN, Hagerman PJ. Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet. 2012 Sep 01; 21(17):3795-805. PMID: 22641815; PMCID: PMC3412379.
    58. Murphy WJ, Nolta J. Autoimmune T cells lured to a FASL web of death by MSCs. Cell Stem Cell. 2012 May 04; 10(5):485-7. PMID: 22560070.
      View in: PubMed
    59. Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M, Bauer G, Nolta J, Anderson JS. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. J Virol. 2012 May; 86(10):5719-29. PMID: 22398281; PMCID: PMC3347262.
    60. Park SS, Caballero S, Bauer G, Shibata B, Roth A, Fitzgerald PG, Forward KI, Zhou P, McGee J, Telander DG, Grant MB, Nolta J. Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2012 Feb; 53(2):986-94. PMID: 22247454; PMCID: PMC3317435.
    61. Mathews G, Sondergaard C, Jeffreys A, Childs W, Le BL, Sahota A, Najibi S, Nolta J, Si MS. Computational analysis of contractility in engineered heart tissue. IEEE Trans Biomed Eng. 2012 May; 59(5):1429-35. PMID: 22361653.
      View in: PubMed
    62. Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med. 2012 Feb 05; 18(3):456-62. PMID: 22306732; PMCID: PMC3755884.
    63. Feng JF, Liu J, Zhang XZ, Zhang L, Jiang JY, Nolta J, Zhao M. Guided migration of neural stem cells derived from human embryonic stem cells by an electric field. Stem Cells. 2012 Feb; 30(2):349-55. PMID: 22076946; PMCID: PMC4437764.
    64. Armstrong L, Lako M, Buckley N, Lappin TR, Murphy MJ, Nolta J, Pittenger M, Stojkovic M. Editorial: Our top 10 developments in stem cell biology over the last 30 years. Stem Cells. 2012 Jan; 30(1):2-9. PMID: 22162299.
      View in: PubMed
    65. Jung Y, Bauer G, Nolta J. Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells. 2012 Jan; 30(1):42-7. PMID: 21898694; PMCID: PMC3784250.
    66. Yarborough M, Tempkin T, Nolta J, Joyce N. The Complex Ethics of First In Human Stem Cell Clinical Trials. AJOB Neurosci. 2012; 3(2). PMID: 24273680.
      View in: PubMed
    67. Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta J. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol. 2012 Feb; 45(1):87-98. PMID: 22161544; PMCID: PMC3259334.
    68. Olson SD, Kambal A, Pollock K, Mitchell GM, Stewart H, Kalomoiris S, Cary W, Nacey C, Pepper K, Nolta J. Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin. Mol Cell Neurosci. 2012 Mar; 49(3):271-81. PMID: 22198539; PMCID: PMC3784251.
    69. Fierro FA, Kalomoiris S, Sondergaard CS, Nolta J. Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells. 2011 Nov; 29(11):1727-37. PMID: 21898687; PMCID: PMC3784258.
    70. Zhou P, Lessa N, Estrada DC, Severson EB, Lingala S, Zern MA, Nolta J, Wu J. Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transpl. 2011 Apr; 17(4):418-27. PMID: 21445925; PMCID: PMC3079538.
    71. Gruenloh W, Kambal A, Sondergaard C, McGee J, Nacey C, Kalomoiris S, Pepper K, Olson S, Fierro F, Nolta J. Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng Part A. 2011 Jun; 17(11-12):1517-25. PMID: 21275830; PMCID: PMC3099448.
    72. Chen X, Lingala S, Khoobyari S, Nolta J, Zern MA, Wu J. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. J Hepatol. 2011 Oct; 55(4):838-45. PMID: 21334406; PMCID: PMC3177032.
    73. Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta J, Anderson JS. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells. Mol Ther. 2011 Mar; 19(3):584-93. PMID: 21119622; PMCID: PMC3048185.
    74. Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta J. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med. 2010 Nov; 5(6):933-46. PMID: 21082892; PMCID: PMC3017479.
    75. Meyerrose T, Olson S, Pontow S, Kalomoiris S, Jung Y, Annett G, Bauer G, Nolta J. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev. 2010 Sep 30; 62(12):1167-74. PMID: 20920540; PMCID: PMC3815452.
    76. Stojkovic M, Pittenger MF, Nolta J, Lako M, Lappin TR, Murphy MJ. Stem Cells' position statement on hESC research. Stem Cells. 2010 Sep; 28(9):1A. PMID: 20809560.
      View in: PubMed
    77. Sondergaard CS, Hodonsky CJ, Khait L, Shaw J, Sarkar B, Birla R, Bove E, Nolta J, Si MS. Human thymus mesenchymal stromal cells augment force production in self-organized cardiac tissue. Ann Thorac Surg. 2010 Sep; 90(3):796-803; discussion 803-4. PMID: 20732499; PMCID: PMC3021786.
    78. Zhou P, Gross S, Liu JH, Yu BY, Feng LL, Nolta J, Sharma V, Piwnica-Worms D, Qiu SX. Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways. FASEB J. 2010 Dec; 24(12):4722-32. PMID: 20696856; PMCID: PMC2992378.
    79. Rosová I, Link D, Nolta J. shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair. Tissue Eng Part A. 2010 Aug; 16(8):2627-39. PMID: 20367286; PMCID: PMC2947453.
    80. Sondergaard CS, Hess DA, Maxwell DJ, Weinheimer C, Rosová I, Creer MH, Piwnica-Worms D, Kovacs A, Pedersen L, Nolta J. Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. J Transl Med. 2010 Mar 09; 8:24. PMID: 20214792; PMCID: PMC2846892.
    81. Anderson JS, Walker J, Nolta J, Bauer G. Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):152-61. PMID: 19593160; PMCID: PMC3777721.
    82. Anderson JS, Javien J, Nolta J, Bauer G. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy. Mol Ther. 2009 Dec; 17(12):2103-14. PMID: 19690520; PMCID: PMC2814390.
    83. Zhou P, Wirthlin L, McGee J, Annett G, Nolta J. Contribution of human hematopoietic stem cells to liver repair. Semin Immunopathol. 2009 Sep; 31(3):411-9. PMID: 19533133; PMCID: PMC2758169.
    84. Zhou P, Hohm S, Olusanya Y, Hess DA, Nolta J. Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model. Hepatology. 2009 Jun; 49(6):1992-2000. PMID: 19437487; PMCID: PMC3030962.
    85. Capoccia BJ, Robson DL, Levac KD, Maxwell DJ, Hohm SA, Neelamkavil MJ, Bell GI, Xenocostas A, Link DC, Piwnica-Worms D, Nolta J, Hess DA. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood. 2009 May 21; 113(21):5340-51. PMID: 19324906; PMCID: PMC2686196.
    86. Rosová I, Dao M, Capoccia B, Link D, Nolta J. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells. 2008 Aug; 26(8):2173-82. PMID: 18511601; PMCID: PMC3017477.
    87. Rich JT, Rosová I, Nolta J, Myckatyn TM, Sandell LJ, McAlinden A. Upregulation of Runx2 and Osterix during in vitro chondrogenesis of human adipose-derived stromal cells. Biochem Biophys Res Commun. 2008 Jul 18; 372(1):230-5. PMID: 18482578; PMCID: PMC2548292.
    88. Bauer G, Dao MA, Case SS, Meyerrose T, Wirthlin L, Zhou P, Wang X, Herrbrich P, Arevalo J, Csik S, Skelton DC, Walker J, Pepper K, Kohn DB, Nolta J. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Mol Ther. 2008 Jul; 16(7):1308-15. PMID: 18461052; PMCID: PMC3013368.
    89. Meyerrose TE, Roberts M, Ohlemiller KK, Vogler CA, Wirthlin L, Nolta J, Sands MS. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells. 2008 Jul; 26(7):1713-22. PMID: 18436861; PMCID: PMC2736639.
    90. Bonde J, Wirthlin L, Kohn DB, Nolta J. Human hematopoietic cell culture, transduction, and analyses. Curr Protoc Hum Genet. 2008 Jan; Chapter 13:Unit 13.7. PMID: 18428422.
      View in: PubMed
    91. Zhou P, Hohm S, Capoccia B, Wirthlin L, Hess D, Link D, Nolta J. Immunodeficient mouse models to study human stem cell-mediated tissue repair. Methods Mol Biol. 2008; 430:213-25. PMID: 18370302.
      View in: PubMed
    92. Wirthlin L, Hess D, Zhou P, Nolta J. Human stem cells for tissue repair. Biol Blood Marrow Transplant. 2008 Jan; 14(1 Suppl 1):151-3. PMID: 18162236.
      View in: PubMed
    93. Maxwell DJ, Bonde J, Hess DA, Hohm SA, Lahey R, Zhou P, Creer MH, Piwnica-Worms D, Nolta J. Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. Stem Cells. 2008 Feb; 26(2):517-24. PMID: 18055451; PMCID: PMC2863008.
    94. Hess DA, Craft TP, Wirthlin L, Hohm S, Zhou P, Eades WC, Creer MH, Sands MS, Nolta J. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells. 2008 Mar; 26(3):611-20. PMID: 18055447; PMCID: PMC3045698.
    95. Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta J, DiPersio JF. Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Exp Hematol. 2007 Dec; 35(12):1823-38. PMID: 17764813; PMCID: PMC2238776.
    96. Qiu SX, Dan C, Ding LS, Peng S, Chen SN, Farnsworth NR, Nolta J, Gross ML, Zhou P. A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways. Chem Biol. 2007 Jul; 14(7):860-9. PMID: 17656322.
      View in: PubMed
    97. Hess DA, Bonde J, Craft TP, Craft TC, Wirthlin L, Hohm S, Lahey R, Todt LM, Dipersio JF, Devine SM, Nolta J. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biol Blood Marrow Transplant. 2007 Apr; 13(4):398-411. PMID: 17382247; PMCID: PMC1868544.
    98. Dao MA, Creer MH, Nolta J, Verfaillie CM. Biology of umbilical cord blood progenitors in bone marrow niches. Blood. 2007 Jul 01; 110(1):74-81. PMID: 17371947; PMCID: PMC1896129.
    99. Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta J, Caruthers SD, Lanza GM, Wickline SA. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 2007 Jun; 21(8):1647-54. PMID: 17284484.
      View in: PubMed
    100. Dao MA, Nolta J. Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow. Blood. 2007 Mar 15; 109(6):2373-9. PMID: 17095623; PMCID: PMC1852192.
    101. Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands MS, Hedrick MA, Nolta J. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells. 2007 Jan; 25(1):220-7. PMID: 16960135; PMCID: PMC4382309.
    102. Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, Eades WC, Creer MH, Nolta J. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood. 2006 Mar 01; 107(5):2162-9. PMID: 16269619; PMCID: PMC1895716.
    103. Smith E, Meyerrose TE, Kohler T, Namdar-Attar M, Bab N, Lahat O, Noh T, Li J, Karaman MW, Hacia JG, Chen TT, Nolta J, Müller R, Bab I, Frenkel B. Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo. Nucleic Acids Res. 2005; 33(4):1298-308. PMID: 15741183; PMCID: PMC552952.
    104. Sohara Y, Shimada H, Minkin C, Erdreich-Epstein A, Nolta J, DeClerck YA. Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. Cancer Res. 2005 Feb 15; 65(4):1129-35. PMID: 15734993.
      View in: PubMed
    105. Bonde J, Hess DA, Nolta J. Recent advances in hematopoietic stem cell biology. Curr Opin Hematol. 2004 Nov; 11(6):392-8. PMID: 15548993.
      View in: PubMed
    106. Mohamedali A, Moreau-Gaudry F, Richard E, Xia P, Nolta J, Malik P. Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cells. Mol Ther. 2004 Aug; 10(2):249-59. PMID: 15294172.
      View in: PubMed
    107. Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, Nolta J. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 2004 Sep 15; 104(6):1648-55. PMID: 15178579.
      View in: PubMed
    108. Meyerrose TE, Herrbrich P, Hess DA, Nolta J. Immune-deficient mouse models for analysis of human stem cells. Biotechniques. 2003 Dec; 35(6):1262-72. PMID: 14682062.
      View in: PubMed
    109. Kohn DB, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviére I, Blau CA, Richard RE, Sorrentino B, Nolta J, Malech H, Brenner M, Cornetta K, Cavagnaro J, High K, Glorioso J. American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol Ther. 2003 Aug; 8(2):180-7. PMID: 12907140.
      View in: PubMed
    110. Schmidt M, Carbonaro DA, Speckmann C, Wissler M, Bohnsack J, Elder M, Aronow BJ, Nolta J, Kohn DB, von Kalle C. Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. Nat Med. 2003 Apr; 9(4):463-8. PMID: 12640448.
      View in: PubMed
    111. Wu GD, Nolta J, Jin YS, Barr ML, Yu H, Starnes VA, Cramer DV. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation. 2003 Mar 15; 75(5):679-85. PMID: 12640309.
      View in: PubMed
    112. Wang X, Ge S, McNamara G, Hao QL, Crooks GM, Nolta J. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood. 2003 May 15; 101(10):4201-8. PMID: 12560238; PMCID: PMC3781008.
    113. Gussoni E, Bennett RR, Muskiewicz KR, Meyerrose T, Nolta J, Gilgoff I, Stein J, Chan YM, Lidov HG, Bönnemann CG, Von Moers A, Morris GE, Den Dunnen JT, Chamberlain JS, Kunkel LM, Weinberg K. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest. 2002 Sep; 110(6):807-14. PMID: 12235112; PMCID: PMC151133.
    114. Dao MA, Arevalo J, Nolta J. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood. 2003 Jan 01; 101(1):112-8. PMID: 12393633.
      View in: PubMed
    115. Dao MA, Hwa J, Nolta J. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors. Blood. 2002 Jan 15; 99(2):499-506. PMID: 11781230; PMCID: PMC4382314.
    116. Dao MA, Nolta J. Retroviral-mediated transduction and clonal integration analysis of human hematopoietic stem and progenitor cells. Methods Mol Med. 2002; 63:253-74. PMID: 21437813.
      View in: PubMed
    117. Parkman R, Weinberg K, Crooks G, Nolta J, Kapoor N, Kohn D. Gene therapy for adenosine deaminase deficiency. Annu Rev Med. 2000; 51:33-47. PMID: 10774451.
      View in: PubMed
    118. Dao M, Nolta J. Molecular control of cell cycle progression in primary human hematopoietic stem cells: methods to increase levels of retroviral-mediated transduction. Leukemia. 1999 Oct; 13(10):1473-80. PMID: 10516745.
      View in: PubMed
    119. Lenarsky C, Weinberg K, Petersen J, Nolta J, Brooks J, Annett G, Kohn D, Parkman R. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission. Bone Marrow Transplant. 1990 Dec; 6(6):425-9. PMID: 2097012.
      View in: PubMed
    120. Ozkaynak MF, Nolta J, Parkman R. In vitro purging of human rhabdomyosarcoma cells using 4-hydroperoxycyclophosphamide. Cancer Res. 1990 Mar 01; 50(5):1455-8. PMID: 2302710.
      View in: PubMed